256 related articles for article (PubMed ID: 37377417)
1. Caspofungin-induced β(1,3)-glucan exposure in
Wagner AS; Lumsdaine SW; Mangrum MM; Reynolds TB
mBio; 2023 Aug; 14(4):e0007423. PubMed ID: 37377417
[TBL] [Abstract][Full Text] [Related]
2. Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans.
Wagner AS; Lumsdaine SW; Mangrum MM; King AE; Hancock TJ; Sparer TE; Reynolds TB
PLoS Genet; 2022 Sep; 18(9):e1010405. PubMed ID: 36121853
[TBL] [Abstract][Full Text] [Related]
3. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Wheeler RT; Kombe D; Agarwala SD; Fink GR
PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
[TBL] [Abstract][Full Text] [Related]
4. Elevated chitin content reduces the susceptibility of Candida species to caspofungin.
Walker LA; Gow NA; Munro CA
Antimicrob Agents Chemother; 2013 Jan; 57(1):146-54. PubMed ID: 23089748
[TBL] [Abstract][Full Text] [Related]
5. Remasking of Candida albicans β-Glucan in Response to Environmental pH Is Regulated by Quorum Sensing.
Cottier F; Sherrington S; Cockerill S; Del Olmo Toledo V; Kissane S; Tournu H; Orsini L; Palmer GE; Pérez JC; Hall RA
mBio; 2019 Oct; 10(5):. PubMed ID: 31615961
[No Abstract] [Full Text] [Related]
6. Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.
Lin J; Wester MJ; Graus MS; Lidke KA; Neumann AK
Mol Biol Cell; 2016 Mar; 27(6):1002-14. PubMed ID: 26792838
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
Rueda C; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
[TBL] [Abstract][Full Text] [Related]
8. β-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity.
Hasim S; Allison DP; Retterer ST; Hopke A; Wheeler RT; Doktycz MJ; Reynolds TB
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849179
[TBL] [Abstract][Full Text] [Related]
9. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
Lee KK; Maccallum DM; Jacobsen MD; Walker LA; Odds FC; Gow NA; Munro CA
Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821
[TBL] [Abstract][Full Text] [Related]
10. Ex-chitin-g news on drug-induced fungal epitope unmasking.
Wheeler RT
mBio; 2023 Oct; 14(5):e0138723. PubMed ID: 37787544
[TBL] [Abstract][Full Text] [Related]
11. Emodin Reduces the Activity of (1,3)-
Janeczko M
Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232
[TBL] [Abstract][Full Text] [Related]
12. The
Ries LNA; Rocha MC; de Castro PA; Silva-Rocha R; Silva RN; Freitas FZ; de Assis LJ; Bertolini MC; Malavazi I; Goldman GH
mBio; 2017 Jun; 8(3):. PubMed ID: 28611248
[No Abstract] [Full Text] [Related]
13. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
Imtiaz T; Lee KK; Munro CA; MacCallum DM; Shankland GS; Johnson EM; MacGregor MS; Bal AM
J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
[TBL] [Abstract][Full Text] [Related]
14. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
[TBL] [Abstract][Full Text] [Related]
15. Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination.
Verwer PE; van Duijn ML; Tavakol M; Bakker-Woudenberg IA; van de Sande WW
Antimicrob Agents Chemother; 2012 Mar; 56(3):1595-8. PubMed ID: 22203603
[TBL] [Abstract][Full Text] [Related]
16. Activation of Cph1 causes ß(1,3)-glucan unmasking in Candida albicans and attenuates virulence in mice in a neutrophil-dependent manner.
Wagner AS; Hancock TJ; Lumsdaine SW; Kauffman SJ; Mangrum MM; Phillips EK; Sparer TE; Reynolds TB
PLoS Pathog; 2021 Aug; 17(8):e1009839. PubMed ID: 34432857
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
[TBL] [Abstract][Full Text] [Related]
18. Nanoscale effects of caspofungin against two yeast species, Saccharomyces cerevisiae and Candida albicans.
Formosa C; Schiavone M; Martin-Yken H; François JM; Duval RE; Dague E
Antimicrob Agents Chemother; 2013 Aug; 57(8):3498-506. PubMed ID: 23669379
[TBL] [Abstract][Full Text] [Related]
19. Lrg1 Regulates β (1,3)-Glucan Masking in Candida albicans through the Cek1 MAP Kinase Pathway.
Chen T; Wagner AS; Tams RN; Eyer JE; Kauffman SJ; Gann ER; Fernandez EJ; Reynolds TB
mBio; 2019 Sep; 10(5):. PubMed ID: 31530671
[No Abstract] [Full Text] [Related]
20. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
